OBJECTIVES
We sought to assess the impact of diabetic retinopathy on long-term outcome among patients with diabetes and multivessel coronary artery disease (MVD) following coronary artery bypass graft surgery (CABG). BACKGROUND For diabetics, CABG is the preferred revascularization strategy. Diabetic retinopathy is a major microvascular complication of diabetes, and its severity is directly related to total glycemic exposure.
METHODS
We identified 223 consecutive diabetics with MVD whose retinae were evaluated within one year prior to CABG. The most recent ophthalmologic records up until the time of CABG were used to evaluate the severity of retinopathy. The median follow-up after CABG was 11.6 years.
RESULTS
Diabetic retinopathy was a strong independent predictor of overall mortality (relative risk [RR], 4.0), and repeat revascularization (RR, 3.0). In separate analyses of diabetics with retinopathy and without retinopathy, predictors of mortality differed significantly between the two groups. Among diabetics with retinopathy, the presence of either preoperative renal (RR, 2.5) or ventricular (RR, 2.0) dysfunction had unfavorable effects on mortality, but the survival curves did not differ significantly according to the presence or absence of internal thoracic artery (ITA) grafting. In comparison, among diabetics without retinopathy, ITA grafting (RR, 0.34) had a beneficial effect on mortality, and the survival curves varied somewhat according to the presence or absence of renal or ventricular dysfunction. CONCLUSIONS Diabetics with retinopathy had a distinct post-CABG course with a worse long-term prognosis, as compared with diabetics without retinopathy. Retina evaluation is useful for prediction of long-term prognosis and management of diabetics who need CABG. Coronary artery bypass graft surgery (CABG) is the preferred strategy for coronary revascularization in patients with diabetes mellitus and multivessel coronary artery disease (MVD) (1) (2) (3) (4) (5) (6) . However, even after CABG, the longterm outcome among diabetics is suboptimal as compared with among nondiabetics. This unfavorable prognosis is believed to be related to more rapid progression of atherosclerosis within native coronary arteries and grafts, a high prevalence of myocardial infarction (MI) and persistence or recurrence of congestive heart failure among diabetics who have undergone CABG (6 -10) . In addition, it was reported that long-term outcome among diabetics after CABG was associated with severity of diabetes at the time of surgery (11) . Diabetic retinopathy (DR) is one of the microvascular complications of diabetes, and its severity is directly related to the severity and duration of hyperglycemia (12) (13) (14) . Recently, epidemiologic studies have reported that patients with severe DR have a high risk of death from coronary artery disease (CAD) (15, 16) . Therefore, diabetics with retinopathy could constitute some proportion of candidates for CABG. However, little is known about the prognostic value of DR among diabetics after CABG. We conducted this study to assess the impact of DR on the long-term outcome of CABG among diabetics. branch retinal artery obstruction). The remaining 223 patients' baseline characteristics concerning demographic data, medical history, coronary risk factors, preoperative and postoperative angiographic data and operative data were collected from medical and surgical records. Causes of death were determined by a review of hospital records and written questionnaires. All repeat revascularization procedures were documented for each patient during the entire follow-up period. The findings reported in this study were documented for all patients as of March 10, 2001 . Assessment of DR. Ophthalmologic records including ophthalmologic charts, fundus photography and fluorescein retinal angiography were reviewed to evaluate patients' retinae. We used the most recent ophthalmologic records up until the time of CABG to approximate the stage of DR at the time of surgery. According to a modification of the Diabetic Retinopathy Study and the Early Treatment Diabetic Retinopathy Study grading scale, the severity in the worst affected eye was used, and the patients with retinopathy were grouped into three categories of retinopathy: those with mild-to-moderate nonproliferative diabetic retinopathy (NPDR) (only microaneurysms or microaneurysms plus one or more the following: retinal hemorrhages, soft exudates, hard exudates, intraretinal microvascular abnormalities or venous beading); those with severe stage of NPDR (at least three of the following: extensive retinal hemorrhages or microaneurysms, soft exudates, intraretinal microvascular abnormalities and venous beading in two or more quadrants); those with proliferative diabetic retinopathy (PDR) (the presence of new vessels, preretinal or vitreous hemorrhages, panretinal photocoagulation scars and a history of vitrectomy) (17, 18) . Statistical analysis. We analyzed the data using SPSS for Windows (version 10.0, SPSS Inc., Tokyo, Japan). Descriptive data for continuous variables are presented as means Ϯ SD. Baseline characteristics of the patient groups were compared by chi-square test or the Fisher exact test for categorical variables. The student t test was used for continuous variables. Overall mortality and repeat revascularization rates were estimated according to Kaplan-Meier methods and were compared using the log-rank test (19, 20) . We used a Cox proportional-hazards model to estimate the prognostic effect of the variables (21). The potential prognostic variables, which were significant in univariate analysis, were entered into the multivariate model. The following variables were considered as potential prognostic variables: older age (Ն65 years), female gender, prior MI, unstable angina, hypertension, current smoking, treatment with insulin, hyperglycemia (blood fasting glucose Ն140 mg/dl), hypercholesterolemia (cholesterol Ն200 mg/dl), high level of low-density lipoprotein cholesterol (Ն140 mg/dl), low level of high-density lipoprotein cholesterol (Յ50 mg/dl), hypertriglyceridemia (triglyceride Ն130 mg/dl), preoperative renal dysfunction (serum creatinine Ն1.4 mg/dl), triplevessel coronary disease, preoperative left ventricular dysfunction (ejection fraction Ͻ50%), internal thoracic artery (ITA) grafting, the small number of grafts used (no. Ͻ3), complete revascularization and the presence of grafts with Ն50% luminal stenosis at discharge. Completeness of revascularization was defined as all diseased coronary systems receiving at least one graft. Two-sided p values of Ͻ0.05 were considered indicative of a statistically significant difference. Table 2 . As compared with diabetics without retinopathy, a larger proportion of diabetics with retinopathy were treated with insulin (p Ͻ 0.001) and had hypertension (p ϭ 0.049). DR and mortality. The average follow-up from the time of CABG was 11.6 Ϯ 4.9 years. During the entire follow-up, of 79 diabetics with retinopathy, 48 (60.8%) died and of 144 diabetics without retinopathy, 27 (18.8%) died. Table 3 shows the causes of death in both groups. Among diabetics with retinopathy, 32 (40.5%) patients died from cardiac causes: 13 (16.5%) patients from acute MI, 18 (22.8%) from congestive heart failure and 1 (1.3%) from ventricular arrhythmia. Diabetics with retinopathy were more likely to die from acute MI (p ϭ 0.008) and from congestive heart failure (p Ͻ 0.001), as compared with diabetics without retinopathy.

Fundus findings.
The 12-year overall mortality was 59.5% (95% confidence interval [CI] , 47.9 to 71.2%) for diabetics with retinopathy and 18.0% (95% CI, 11.5 to 24.5%) for diabetics without retinopathy. As shown in Figure 1A , overall survival curves differed significantly according to the presence or absence of retinopathy (p Ͻ 0.001). Multivariate analysis demonstrated Figure 1B , repeat revascularization rate curves differed significantly between the two groups (p Ͻ 0.001). Multivariate analysis showed that the presence of retinopathy was an independent predictor of repeat revascularization (adjusted RR, 3.04; 95% CI, 1.89 to 4.87; p Ͻ 0.001). Separate analyses of diabetics with retinopathy and without retinopathy. Diabetics with retinopathy had a distinct post-CABG course from diabetics without retinopathy. Therefore, we studied predictors of all-causes death of the two groups separately. Predictors of overall mortality were significantly different between the two groups ( (Fig. 4) . In comparison, among diabetics without retinopathy the survival curves were similar according to the presence or absence of preoperative renal (Fig. 2) or left ventricular dysfunction (Fig. 3) 
DISCUSSION
It has been demonstrated that diabetics with retinopathy have a distinct post-CABG course different from diabetics without retinopathy. Outcome among diabetics with retinopathy was characterized by high mortality and high repeat revascularization rate. In contrast, long-term survival among diabetics without retinopathy was excellent particularly when they underwent ITA grafting. The Bypass Angioplasty Revascularization Investigation reported a seven-year overall survival after CABG among nondiabetics of 86.4% and the Emory Angioplasty versus Surgery Trial reported 84% at eight years (2, 3) . In our study, overall survival rate among diabetics without retinopathy was 87.5% at seven years and 84.7% at eight years. We cannot directly compare Ono et al. August 7, 2002:428-36 DR and CABG our results with previous reports because characteristics of patients and methods of studies are different. Nevertheless, in the present study long-term survival of diabetics without retinopathy seems to be as good as that of nondiabetics in other studies. Repeat revascularization could have been due to: 1) completeness of revascularization; 2) surgical technique; 3) state of the coronary artery at initial CABG; and 4) progression of atherosclerosis within native coronary arteries and grafts following CABG. As for completeness of revascularization, we aimed at complete revascularization for all patients. However, complete revascularization was not always technically possible because of poor distal target vessel. 
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In our study, the absence of complete revascularization was a predictor of repeat revascularization (RR, 1.65; 95% CI, 1.03 to 2.65; p ϭ 0.039) in the univariate analysis, but was not an independent predictor in the multivariate analysis. As for surgical technique, in our hospital, cardiac catheterization was performed before discharge in all patients so as to access surgical success. The presence of grafts with luminal stenosis at discharge was not a predictor of repeat revascu- larization in our study. In addition, the rates of patency of the grafts did not vary according to the presence or absence of retinopathy.
Regarding the state of the coronary artery at initial CABG, our study demonstrated that the presence of triplevessel disease was not a predictor of repeat revascularization, and the presence of DR at CABG was a strong independent predictor. We believe that diabetics with retinopathy might have more diffuse coronary disease, compared with diabetics without retinopathy, although a proportion of patients with triple-vessel disease did not differ significantly between the two groups. More diffuse coronary disease among diabetics with retinopathy might partly contribute to high repeat revascularization.
As for the progression of atherosclerosis within native coronary arteries and grafts following CABG, it is generally accepted that retinopathy does not correlate directly with macrovascular atherosclerosis within native coronary arteries and grafts. However, the association of retinopathy with microvascular dysfunction in turn probably could have a direct effect on progression of atherosclerosis. One possible explanation is that DR correlates with duration of disease, the severity of hyperglycemia and the adequacy of diabetic control. Diabetics with retinopathy, therefore, have had a longer period of poor-controlled diabetes and, therefore, are much more likely to have additional comorbidities and aggressive disease. In our study, diabetics with retinopathy were more likely to have hypertension. In addition, DR may be a marker of diabetic nephropathy. It is the hypertension and renal disease that are associated with progressive atherosclerosis.
In our study, the overall survival did not differ significantly among diabetics with and without ITA grafting in the presence of DR. This suggests that the effect of ITA grafting on the long-term survival among diabetics with retinopathy might be much smaller than among diabetes without retinopathy. The possible explanation is that among diabetics with retinopathy and advanced vascular disease, the benefit of ITA graft becomes small, because target distal coronary arteries are poor and diseased diffusely. Conversely, among diabetics without retinopathy, the caliber of the vessels may be better, which enables the superiority of the ITA on survival to become manifest.
It is interesting that in the absence of retinopathy there is really no difference in overall survival among patients with and without renal dysfunction. The most likely explanation is that renal dysfunction in diabetics without retinopathy is not related to diabetic nephropathy. It may be that these are patients with renal dysfunction due to other factors such as hypertension. This may be why their prognosis is good. We have shown that among diabetics with retinopathy the presence of preoperative left ventricular dysfunction had an unfavorable effect on survival. This finding might suggest that CABG conferred small improvement in survival and ventricular function among patients with these characteristics. In contrast, among diabetics without retinopathy the survival curves for patients with preoperative ventricular dysfunction were similar to those of patients without left ventricular dysfunction, suggesting that CABG conferred a significant improvement in ventricular function. Nahser et al. (22) reported that, in diabetics, coronary microvascular abnormalities may lead to myocardial ischemia in the absence of epicardial coronary atherosclerosis and contribute to ventricular dysfunction. We speculate that coronary microvascular abnormalities among diabetics with retinopathy is more profound than that among diabetics without retinopathy and that this difference may explain the unequal improvement after CABG between the two groups. Because CABG "bypasses" only the epicardial stenotic site of coronary artery, CABG alone might not be sufficient to improve ventricular function among diabetics with retinopathy.
The Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction study showed that tight glucose control reduced the risk of mortality after MI in diabetics (23, 24) . Several studies reported that poor glycemic control was associated with an increased risk of heart failure among diabetics (25, 26) . Considering that these adverse outcomes were more frequent among diabetics with retinopathy, it would be in this group of patients that a significant benefit could be conferred from strict glycemic control with insulin after CABG.
Nowhere is this more "visible" than in the eye, where the retinal circulation is thought to represent the cerebrovascular circulation because the retina develops from the forebrain (27) . Furthermore, the retinal changes parallel the duration and severity of diabetes. We found a significant, graded association between the severity of retinopathy and overall mortality after CABG. Therefore, evaluation of retinopathy may provide a useful means of stratifying risk in the heterogeneous group of diabetics with coronary artery disease. Eye examination can be readily performed at the bedside using the direct ophthalmoscope and, therefore, is recommended for all diabetics who need coronary revascularization. Study limitations. The present study has some limitations. First, our study included diabetics who had undergone eye examination at any time from one year up until CABG. Hence, the severity of retinopathy at the time of CABG may have been underestimated. Second, unrecognized biases might have led to the selection of patients referred for Ono et al. August 7, 2002:428-36 DR and CABG
